首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿苯达唑-壳聚糖微球的制备及其质量指标的考察
引用本文:张光宇,晏语,倪进,王晓青,杨程,张学农,任伟新,迪理木拉提·巴吾东,顾俊鹏,许晓东.阿苯达唑-壳聚糖微球的制备及其质量指标的考察[J].抗感染药学,2012,9(2):108-114.
作者姓名:张光宇  晏语  倪进  王晓青  杨程  张学农  任伟新  迪理木拉提·巴吾东  顾俊鹏  许晓东
作者单位:1. 苏州大学医学部药学院,江苏苏州215123;新疆医科大学附属第一医院,新疆乌鲁木齐830054
2. 苏州大学医学部药学院,江苏苏州,215123
3. 新疆医科大学附属第一医院,新疆乌鲁木齐,830054
基金项目:国家自然科学基金,国家科技部十一五"重大新药创制"技术平台项目资助,国家科技支撑计划课题资助
摘    要:目的:考察阿苯达唑-壳聚糖微球(ABZ-CS-MS)的载药量、包封率、表面形态及结果特性,以及微球在不同介质中的体外释放特性。方法:采用乳化-交联固化法,以液体石蜡为油相,Span-80为乳化剂,戊二醛为交联剂,壳聚糖(chitosan,CS)为载体,制备阿苯达唑-壳聚糖微球(ABZ-CS-MS);应用光学显微镜测量ABZ-CS-MS的的粒径大小及其分布;用扫描电镜(SEM)观察ABZ-CS-MS的表面形态;用红外光谱(fourier transform infraredspectrometer,FT-IR)、X-线粉末衍射法(X-ray power diffraction,X-RD)和差示扫描热量法(differential scanning calo-rimetry,DSC)检测ABZ-CS-MS的特性;用体外动态透析法测定ABZ-CS-MS在不同介质条件下的释药性能。结果:所制备的ABZ-CS-MS形态圆整,粒径分布较为均匀,平均粒径为(153±7)μm,载药量为(20.92±0.15)%,包封率为(25.37±0.22)%;ABZ-CS-MS分别在不同介质(0.1mol/L HCl液、PBS(pH=3.5)、PBS(pH=7.4)和0.9%氯化钠溶液)中的释放均遵循Weibull方程,其中在PBS(pH=3.5)中释放效果最佳。结论:该法制备的ABZ-CS-MS的质量与性能良好,具有较好的载药量,包封率高,形态圆整,缓释作用明显。

关 键 词:阿苯达唑  壳聚糖  肝动脉栓塞  微球  制备  体外释放

Studies on Preparation and Quality Evaluation of Albendazole Loaded-Chitosan Microspheres
ZHANG Guang-yu , Yan Yu , Ni Jin , WANG Xiao-qing , Yang Cheng , ZHANG Xue-nong , REN Wei-xin , Dilimulati· Bawudong , GU Jun-peng , XU Xiao-dong.Studies on Preparation and Quality Evaluation of Albendazole Loaded-Chitosan Microspheres[J].Anti-infection Pharmacy,2012,9(2):108-114.
Authors:ZHANG Guang-yu  Yan Yu  Ni Jin  WANG Xiao-qing  Yang Cheng  ZHANG Xue-nong  REN Wei-xin  Dilimulati· Bawudong  GU Jun-peng  XU Xiao-dong
Institution:1School of Pharmaceutical science,Soochow University,Suzhou Jiangsu 215123,China The No.1 Hospital Affiliated to Xinjiang medical university Urumqi Xinjiang 830054 China
Abstract:Objective:To study the preparation technique of ABZ-CS-MS the encapsulation efficiency the drug-loading rate the average diameter and shape were investigated.Methods:albendazole-loaded chitosan microspheres for embolization were achieved by emulsification cross-linking process with liquid paraffin as oil phase chitosan as water phase Span-80 as emulsifier and glutaraldehyde as cross linking agent.The particle size and distribution of microspheres were analyzed by optical microscope and the surface characterization of the microspheres was identified with scanning electronic microscope(SEM).The interaction of the drug and the polymer was analyzed by Application of infrared spectroscopy(FT-IR) X-ray power diffraction(XRD) and differential scanning calorimetry(DSC).Results:The novel microspheres with a global shape and narrow distribution were prepared.The average diameter was about(153±7)μm the drug-Loading rate was(20.92±0.15)% and the encapsulation efficiency of microspheres was(25.37±0.22)%.The drug release behavior at 0.1 mol/L HCL phosphate buffered saline(pH=3.5) and phosphate buffered saline(pH=7.4) and physiological saline are all conformed weibull distribution model the best effect of which is in PBS(pH= 3.5).Conclusion:The technique was feasible and microspheres with high drug-Loading rate and evident effect of sustained drug release were prepared.The solubility property of the albendazole solid dispersions was increased obviously.
Keywords:albendazole  chitosan  microspheres  preparation  release in vitro
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号